Recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) is a devastating malignancy with a poor prognosis. Treatment is limited to chemotherapeutic approaches. Cisplatin is an established and effective treatment for R/M HNSCC, and many studies have investigated cisplatin treatment in combination with other agents. Even when being treated with first line therapy…
Clinical Medicine Insights Therapeutics Template
Write in a clean editor, then format for Clinical Medicine Insights Therapeutics in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Clinical Medicine Insights Therapeutics format
Clinical Medicine Insights Therapeutics is a peer-reviewed journal published by SAGE, covering Asthma and respiratory diseases, Diabetes Treatment and Management, Chronic Lymphocytic Leukemia Research.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Clinical Medicine Insights Therapeutics, 12(3), pp. 45–58.
Formats any DOI in Clinical Medicine Insights Therapeutics style. No sign-up. |
| Publishes research in | Asthma and respiratory diseases Diabetes Treatment and Management Chronic Lymphocytic Leukemia Research Atrial Fibrillation Management and Outcomes Neuroscience and Neuropharmacology Research |
| ISSN | 1179-559X |
| h-index | 15 |
| i10-index | 28 |
| Total citations | 1,035 |
| Open access | Yes |
| Top institutions publishing here | Creighton University |
| Journal website | www.la-press.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Clinical Medicine Insights Therapeutics per year
Citation impact of Clinical Medicine Insights Therapeutics by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Clinical Medicine Insights Therapeutics
Nonalcoholic fatty liver disease (NAFLD) is on the rise and has become a major etiology for chronic liver disease. It is frequently associated with obesity, insulin resistance, hypertension, and dyslipidemia and is considered the hepatic manifestation of metabolic syndrome. In this review, we present a summary of the epidemiology and pathogenesis of NAFLD, and discuss…
The sirolimus-eluting stent (SES) Cypher was the first commercially available drug-eluting stent. The use of this stent has resulted in significantly lower rates of restenosis and lesion revascularization compared to bare metal stents and balloon angioplasty. In this review, angiographic and clinical outcomes in patients treated with SES are compared to those treated with bare…
Background: Wound infections constitute a significant problem in surgical procedures. In cesarean sections (CS), this is particularly important as a wound infection not only results in increased morbidity but also has far-reaching implications by way of pelvic organ disease, disturbance of the bonding process between mother and baby in the puerperium, and a longer hospital…
Donepezil is a potent, selective, noncompetitive, and rapidly reversible inhibitor of acetylcholinesterase (AChEI) licensed for the treatment of Alzheimer disease (AD); and is the first and only AChEI licensed for the treatment of severe AD. Its efficacy as monotherapy, or in combination with the NMDA-agonist, memantine, has been documented in several randomised double-blind, placebo-controlled, short-term…